Article Information
PubMed
Print ISSN
Online ISSN
History
- Published online August 29, 2020.
Article Versions
- You are currently viewing an Earlier version of this article (August 29, 2020 - 05:17).
- View the most recent version of this article
Copyright & Usage
Copyright © 2020 American Society for Pharmacology and Experimental Therapeutics
Author Information
- Noriko Hino1,
- Toshiyuki Marumo1,
- Makiko Kotani1,
- Toshiharu Shimazaki1,
- Ayaka Kaku-Fukumoto1,
- Hirohiko Hikichi1,
- Jun-ichi Karasawa1,
- Yasumitsu Tomishima1,
- Hiroko Komiyama1,
- Emi Tatsuda1,
- Dai Nozawa1,
- Toshio Nakamura2, and
- Shigeyuki Chaki1,*
- 1Research Headquarters, Taisho Pharmaceutical Co., Ltd., Japan
- 2Taisho Pharmaceutical Co., Ltd., Japan
- ↵* Corresponding Author:
Shigeyuki Chaki, Research Headquarters, Taisho Pharmaceutical Co., Ltd., 1-403 Yoshino-cho, Kita-ku, Saitama, N/A, 331-9530, Japan. E-mail: s-chaki{at}taisho.co.jp
Statistics from Altmetric.com
Article usage
In this issue
Pharmacological profiles of enelisant
